Predictive Indicators of Kinematic Writing Ability in Patients with Parkinson's Disease: Focusing on Cognition, Depression, and Motor Abilities (vol 27, pg 128, 2022)

被引：0

作者：

Lee, Han Sol ^{[1
]}

Youn, Jinyoung ^{[2
,3
]}

Ahn, Jong Hyeon ^{[2
,3
]}

Cho, Jin Whan ^{[2
,3
]}

Na, Duk L. ^{[2
,3
,4
,5
]}

Yoon, Ji Hye ^{[6
]}

机构：

[1] Hallym Univ, Grad Sch, Dept Speech Language Pathol & Audiol, Chunchon, South Korea

[2] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Neurol, Seoul, South Korea

[3] Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea

[4] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea

[5] Samsung Alzheimer Res Ctr, Samsung Med Ctr, Seoul, South Korea

[6] Hallym Univ, Coll Nat Sci, Res Inst Audiol & Speech Pathol, Div Speech Pathol & Audiol, Chunchon, South Korea

来源：

COMMUNICATION SCIENCES AND DISORDERS-CSD | 2022年 / 27卷 / 02期

基金：

新加坡国家研究基金会;

关键词：

D O I：

10.12963/csd.22887.e1

中图分类号：

R36 [病理学]; R76 [耳鼻咽喉科学];

学科分类号：

100104 ; 100213 ;

摘要：

引用

页码：444 / 444

页数：1

共 15 条

[11] Effects of Ten Different Exercise Interventions on Motor Function in Parkinson's Disease Patients-A Network Meta-Analysis of Randomized Controlled Trials (vol 12, 698, 2022)
Hao, Zikang
Zhang, Xiaodan
Chen, Ping
BRAIN SCIENCES, 2023, 13 (06)
[12] 4-Phenylbutyrate Mitigates the Motor Impairment and Dopaminergic Neuronal Death During Parkinson's Disease Pathology via Targeting VDAC1 Mediated Mitochondrial Function and Astrocytes Activation (vol 47, pg 3385, 2022)
Tiwari, Shubhangini
Gupta, Parul
Singh, Abhishek
Chaturvedi, Swati
Wahajuddin, M.
Mishra, Amit
Singh, Sarika
NEUROCHEMICAL RESEARCH, 2023, 48 (10) : 3251 - 3252
[13] Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial (vol 21, pg 1099, 2022)
Soileau, M. J.
Aldread, J.
Budur, K.
LANCET NEUROLOGY, 2023, 22 (03): : E5 - E5
[14] Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes (vol 21, pg 231, 2015)
Antonini, Angelo
Yegin, Ashley
Preda, Cornelia
Bergmann, Lars
Poewe, Werner
PARKINSONISM & RELATED DISORDERS, 2016, 31 : 162 - 162
[15] Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebocontrolled phase 3 trial (vol 18, pg 145, 2019)
LeWitt, P. A.
Hauser, R. A.
Pahwa, R.
LANCET NEUROLOGY, 2019, 18 (03): : E2 - E2

← 1 2 →